On the other hand, trans and saturated fatty acids not only reduce PPARγ expression but are also associated with increased inflammation and impaired lipid metabolism, which can raise the risk of metabolic diseases such as nonalcoholic fatty liver disease and metabolic syndrome [33, 34]. Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.